FDA criticised for rejecting over the counter emergency contraception

BMJ 2005; 331 doi: (Published 24 November 2005) Cite this as: BMJ 2005;331:1223
  1. Janice Hopkins Tanne
  1. New York

    The US Food and Drug Administration's decision to refuse to approve over the counter status for the emergency contraceptive Plan B (levonorgestrel) was flawed, unusual, and not standard FDA procedure. This is finding of a report by the Government Accountability Office, an independent investigative agency of the US Congress.

    Two FDA officials resigned in protest over the denial (BMJ 2005;331: 532, 861).

    Forty eight senators and representatives …

    View Full Text

    Sign in

    Log in through your institution